What is Enanta Pharmaceuticals, Inc's Market Cap?

Enanta Pharmaceuticals, Inc's Market Cap is $385.6M, based on as-reported figures from SEC (XBRL) filings.

What is Enanta Pharmaceuticals, Inc's Enterprise Value?

Enanta Pharmaceuticals, Inc's Enterprise Value is $352.2M, based on as-reported figures from SEC (XBRL) filings.

What is Enanta Pharmaceuticals, Inc's Price / Sales?

Enanta Pharmaceuticals, Inc's Price / Sales is 5.9×, based on as-reported figures from SEC (XBRL) filings.

What is Enanta Pharmaceuticals, Inc's EV / Revenue?

Enanta Pharmaceuticals, Inc's EV / Revenue is 5.4×, based on as-reported figures from SEC (XBRL) filings.

What is Enanta Pharmaceuticals, Inc's EV / EBITDA?

Enanta Pharmaceuticals, Inc's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Enanta Pharmaceuticals, Inc's Revenue (TTM)?

Enanta Pharmaceuticals, Inc's Revenue (TTM) is $65.3M, based on as-reported figures from SEC (XBRL) filings.

What is Enanta Pharmaceuticals, Inc's Net Income (TTM)?

Enanta Pharmaceuticals, Inc's Net Income (TTM) is -$63.2M, based on as-reported figures from SEC (XBRL) filings.

What is Enanta Pharmaceuticals, Inc's EBITDA?

Enanta Pharmaceuticals, Inc's EBITDA is -$53.8M, based on as-reported figures from SEC (XBRL) filings.

What is Enanta Pharmaceuticals, Inc's Diluted EPS (TTM)?

Enanta Pharmaceuticals, Inc's Diluted EPS (TTM) is -2.17, based on as-reported figures from SEC (XBRL) filings.

What is Enanta Pharmaceuticals, Inc's EBITDA Margin?

Enanta Pharmaceuticals, Inc's EBITDA Margin is -82.5%, based on as-reported figures from SEC (XBRL) filings.

Enanta Pharmaceuticals, Inc (ENTA) Financial Statements

Enanta Pharmaceuticals, Inc

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001V9NSC3

XNAS · usd

13.24▼ 0.26 (-1.93%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close13.50

Day's Range13.09 – 13.51

52-Week Range7.05 – 17.15

Volume192.9K

Avg Volume211.7K

Share Statistics

Shares Outstanding

Employees120

ExchangeXNAS

Listed2013-03-21

Share count as of August 7, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Enanta Pharmaceuticals, Inc (ENTA)

What is Enanta Pharmaceuticals, Inc's Market Cap?: Enanta Pharmaceuticals, Inc's Market Cap is $385.6M, based on as-reported figures from SEC (XBRL) filings.
What is Enanta Pharmaceuticals, Inc's Enterprise Value?: Enanta Pharmaceuticals, Inc's Enterprise Value is $352.2M, based on as-reported figures from SEC (XBRL) filings.
What is Enanta Pharmaceuticals, Inc's Price / Sales?: Enanta Pharmaceuticals, Inc's Price / Sales is 5.9×, based on as-reported figures from SEC (XBRL) filings.
What is Enanta Pharmaceuticals, Inc's EV / Revenue?: Enanta Pharmaceuticals, Inc's EV / Revenue is 5.4×, based on as-reported figures from SEC (XBRL) filings.
What is Enanta Pharmaceuticals, Inc's EV / EBITDA?: Enanta Pharmaceuticals, Inc's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Enanta Pharmaceuticals, Inc's Revenue (TTM)?: Enanta Pharmaceuticals, Inc's Revenue (TTM) is $65.3M, based on as-reported figures from SEC (XBRL) filings.
What is Enanta Pharmaceuticals, Inc's Net Income (TTM)?: Enanta Pharmaceuticals, Inc's Net Income (TTM) is -$63.2M, based on as-reported figures from SEC (XBRL) filings.
What is Enanta Pharmaceuticals, Inc's EBITDA?: Enanta Pharmaceuticals, Inc's EBITDA is -$53.8M, based on as-reported figures from SEC (XBRL) filings.
What is Enanta Pharmaceuticals, Inc's Diluted EPS (TTM)?: Enanta Pharmaceuticals, Inc's Diluted EPS (TTM) is -2.17, based on as-reported figures from SEC (XBRL) filings.
What is Enanta Pharmaceuticals, Inc's EBITDA Margin?: Enanta Pharmaceuticals, Inc's EBITDA Margin is -82.5%, based on as-reported figures from SEC (XBRL) filings.